Publications
5532 Results
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 31(Suppl.2):S213-S216
- Year
- 1993
- Research Committee(s)
- Sarcoma
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic soft tissue sarcomas. A Southwest Oncology Group study.
- Journal / Conference
- IND 11:45-46
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8712
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Anti-Cancer Drugs 4:49-50
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8714
Phase II trial of amonafide in advanced colorectal cancer: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 71(8):2631-2638
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8231
Alternating combination chemotherapy in patients with extragonadal germ cell tumors: A Southwest Oncology Group study.
- Journal / Conference
- Journal of Urology 150:411-413
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8302
Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: A Southwest Oncology Group study.
- Journal / Conference
- Oncology Nursing Forum 20(9):1415-1419
- Year
- 1993
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8313 (EST 5186)
Pitfalls in quality-of-life assessment: Lessons from a Southwest Oncology Group breast cancer clinical trial.
- Journal / Conference
- Cancer 71(2):618-627
- Year
- 1993
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.
- Journal / Conference
- Journal of Neuro-Oncology 15:75-77
- Year
- 1993
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-8415
A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group study.
- Journal / Conference
- Blood 81(2):490-495
- Year
- 1993
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624